stockrow
Friday 6 November 2026
Export OM’s income statement to Excel — free account
Outset Medical, Inc.
Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024.
- Revenue
- +14.2%
- EPS
- +22.0%
- Free cash flow
- −61.9%
- Total debt
- +4.20%
Quarter to September 2026, against a year earlier
4.17
0.07
+1.71%
Follow OM
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 4 | 4 | — |
| (106.20%) | (53.90%) | (60.09%) | (64.14%) | ||
| (30.23%) | (27.18%) | (27.97%) | (28.03%) | ||
ROIC |
(76.86%) | (80.83%) | (86.10%) | 0.00% | |
Return on Tangible Assets |
(37.47%) | (36.84%) | (39.59%) | (40.58%) | |
Average Days of Receivables |
86.55 | 78.60 | 90.54 | 91.00 | |
Free Cash Flow per Share |
(3.10) | (1.86) | (2.09) | 0.00 | |
Free Cash Flow |
(47.12) | (34.25) | (38.88) | (42.89) | |
Capital Expenditures |
(0.80) | (0.74) | (0.56) | (0.51) | |
| Other line items | |||||
Cash ROIC |
(12.02%) | (9.37%) | (11.36%) | (19.50%) | |
Accounts Receivable Turnover |
3.74 | 3.78 | 3.67 | 3.85 | |
Accounts Payable Turnover |
32.94 | 53.45 | 23.26 | 23.50 | |
Inventory Turnover |
1.36 | 1.32 | 1.38 | 1.50 | |
Average Days of Payables |
2.78 | 7.53 | 23.70 | 22.16 | |
Days of Inventory on Hand |
238.96 | 259.62 | 251.73 | 232.30 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
17.77% | 18.15% | 18.25% | 18.05% | |
Selling, General and Administrative Expense of Revenue |
77.19% | 79.66% | 79.57% | 75.23% | |
Share Based Compensation of Revenue |
13.07% | 13.69% | 12.98% | 9.76% | |
Interest Coverage |
(4.78) | (4.89) | (4.81) | (4.54) | |
Operating CF/Net income |
0.57 | 0.45 | 0.52 | 0.60 | |
Depreciation/Fixed assets |
0.45 | 0.39 | 0.35 | 0.36 | |
Capex/Depreciation |
(0.38) | (0.47) | (0.43) | (0.40) | |
Revenue per Share |
7.85 | 6.40 | 6.33 | 0.00 | |
Operating CF per Share |
(3.05) | (1.82) | (2.06) | 0.00 | |
Capex per Share |
(0.05) | (0.04) | (0.03) | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026